characterized by Southern blot and or by RT-PCR. In summary, cDNA samples were subjected to PCR using primers specific to each MLL translocation: t(10;11), t(11;19), t(4;11). The G3PHD gene was used as an internal reaction control. From the five cases without MLL involvement, no rearrangement was detected in four cases by Southern blot analysis, while an inversion [inv(11;11)(q23;p13)] was found in a single case.
PCR reactions were next made on cDNA using specific primers to the AT-hook region (CAGTACAAAATGGCCAGTGC and TGTAAGTGGAGGTGTTCCTTCC). For each reaction 50 ml mix was used: 10 pmol of each primer; 50-100 ng of cDNA; 200 mM dNTP; 2 U Taq Polymerase (Pharmacia); Taq buffer 1% and DMSO 1%. The PCR conditions consisted of an initial denaturation at 941C for 3 min followed by 30 cycles: denaturation of 941C for 45 s, annealing at 551C for 45 s, extending at 721C for 1 min and a final elongation of 5 min. The products were gel purified and subjected to DNA sequencing using a DYEnamic ET Terminator kit (Pharmacia). The Sequence Navigator program was used to analyze the results and compare sequence obtained from the patients to the standard MLL gene sequence (accession no. D14540).
MLL fusions are very common in ALs in infants and probably arise in utero. 6, 7 via transplacental exposure to genotoxic chemicals. 8 Although this selectivity of MLL to infant AL is not completely understood, it raises the possibility that alterations in MLL, other than by gene fusion, might also be involved in some cases. The AThook region was chosen for study because of its previously reported importance in the malignant process, with the hypothesis that alterations in these motifs might provoke MLL loss of function.
Of the 23 MLL AT-hook sequences analyzed, all of them were conserved. No mutations were found in any of the studied cases with MLL gene fusion or of wild-type MLL in those cases that lacked a fusion gene. N-terminal MLL, including the AT-hook region is responsible for MLL nuclear localization, so either native or chimeric MLL proteins will share the same nuclear localization in vitro. 5 Sequence conservation of the AT-hooks points to the fact that MLL nuclear localization in vivo will occur with both native and chimeric proteins. Considering that localization is important both for DNA binding and protein action, the conservation of MLL AThook sequences that we have found (even in cases of infant AL without MLL gene rearrangement) might be essential for the transformation properties of the chimeric proteins. 
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TO THE EDITOR
The bcl-2 translocation is a genetic alteration involved in lymphomagenesis, especially in lymphomas for which an antigendriven pathogenetic mechanism has been hypothesized, such as follicular lymphoma (FL) and salivary gland non-Hodgkin's lymphoma (NHL) in patients with Sjö gren's syndrome. Previous studies of B-cell lymphoproliferation in hepatitis C virus (HCV)-infected patients are consistent with an antigen-driven process and support a role for antigens associated with HCV in chronic stimulation of Bcell proliferation, particularly in individuals with type II mixed cryoglobulinemia (MC) syndrome. To examine the possible relation between bcl-2/IgH translocation and HCV-associated NHLs, neoplastic biopsy specimens and PBMCs from 48 NHL patients infected with HCV were analyzed for bcl-2/IgH translocation. The majority of bcl-2 rearrangements occur at two distinct chromosomal sites known as the major breakpoint cluster region (MBR) and the minor cluster region (mcr). Each DNA sample (0.5 mg) was analyzed by PCR as described by Zuckerman (Table 1) . Sequence analysis of MBR PCR products from two lymphoma biopsy specimens confirmed the presence of the bcl-2/IgH breakpoint in patients #13 and #23, which respectively did and did not have concomitant MC syndrome ( Figure 1) . None of the lymphoma biopsy specimens were positive for translocation at the mcr. Thus, the frequency of t(14;18) translocation observed in PBMCs (groups III and IV) was higher than that of neoplastic tissue (groups I and II). Both lymphoma biopsy specimen and PBMC were analyzed for seven HCV-infected NHL patients. Among lymphoma biopsy specimens, the t(14;18) translocation was observed in only one of these seven patients. In contrast, this translocation was detected in PBMCs from five of these seven patients. Of the five HCV-infected NHL patients with PBMCs positive for t(14;18) translocation, only one had FL. This patient, #14, accounted for the single lymphoma positive for t(14;18) translocation. PCR products amplified from the lymphoma biopsy specimen as well as PBMCs from patient #14 were found to have identical bcl-2/IgH rearrangements following sequence analysis (data not shown). This result, although limited to one patient, suggests the patients PBMCs and follicular lymphoma cells with this translocation had a common origin. Bcl-2 expression was also investigated by immunohistochemistry in lymphoma biopsy specimens from the remaining four HCV-infected NHL patients with PBMCs positive for t(14;18) translocation. Of these for NHLs, one demonstrated elevated Bcl-2 immunoreactivity. Thus, Bcl-2 overexpression in NHLs may occur in patients with chronic HCV infection by a mechanism different from bcl-2 translocation as has been previously reported. 5 The frequency of bcl-2 translocation observed in PBMCs from HCV-infected NHL patients is similar to that reported elsewhere 2, 3 for HCV-infected patients without NHL. Our data also demonstrated a low frequency of bcl-2 translocation in neoplastic tissue from HCV-associated lymphomas that is in agreement with previous studies, although they concerned a limited number of cases. 5, 6 These results suggest that bcl-2 translocation is not involved in HCV-associated lymphomagenesis.
We also studied PBMCs from two groups of HCV-negative individuals as controls. The first group was composed of 135 randomly selected patients with B-cell NHL. Of these, 65 had FL. The second group was composed of 50 healthy donors. A higher frequency of t(14;18) translocation was evident in PBMCs from NHL patients (49/135; 36.3%) in comparison to healthy individuals (0/50; 0.0%) (Po0.05). Additionally, this translocation was more frequent in FL patients (38/65; 58.5%) than patients with non-FL NHL histotypes (11/70; 15.7%) (Pp0.05). We also analyzed corresponding neoplastic tissue from 13 of the HCV-negative FL patients in which we detected t(14;18) translocation in PBMCs. In all 13 of these patients, bcl-2 rearrangement was also observed in their lymphoma biopsy specimens. These findings indicate that bcl-2 translocation detected in PBMCs is particularly strongly associated with FL NHLs. Notably, FLs have been observed to be infrequent
Patient 13
MBRin primer ______________________________________________ BCL-2 ____________________________________ tatggtggtttgacctttagagagttgctttacgtggcctgtttcaacacagacccacccagagccctcctgccctccttccgcgggggctttctcatggctgtccttcagggtcttcctgaaatgca
_________________BCL-2_____________________________
__________ Figure 1 (a) Detection of bcl-2/IgH translocation in lymphoma biopsy specimens from NHL patients with chronic HCV infection by nested PCR. PCR products were separated by electrophoresis with a 2.5% agarose gel then stained with ethidium bromide. Single dominant bands were observed from patients #13 and #23, which respectively did and did not have concomitant MC syndrome. Translocation of bcl-2 was not detected in patients #3 and #9, which both had MC syndrome. Symbols: (F), molecular weight marker F Â dig. Hae III; (À), negative control; (+), positive control. (b) DNA sequences of gel-purified PCR products amplified from lymphoma biopsy specimens from patients #13 and #23. Lightning bolts indicate bcl-2/IgH breakpoints.
among HCV-infected patients. 7, 8 Only three of 48 HCV-infected patients had FL in the present study, which is consistent with previous findings.
Bcl-2 rearrangement could be detected in PBMCs from a small proportion of healthy individuals. 9 However, rarely these individuals subsequently developed a lymphoma. Evidently, the additional oncogenic hits that lead to malignant transformation occur rarely in B cells with bcl-2 translocation. In the present study, t(14;18) translocation was not shown to be any more frequent among HCV-infected NHL patients than HCV-negative NHL patients. The observation that bcl-2 rearrangement is more common in patients with FL than those with other NHLs may be a contributory factor to explain our finding that HCV-infected NHL patients did not have a higher frequency of bcl-2 rearrangement than HCV-negative NHL patients, who are more likely to have FL. Therefore, t(14;18) translocation in PBMCs from HCV-infected patients does not appear to be a predictive marker of lymphomagenesis. The cause of the increased frequency of bcl-2 rearrangement in PBMCs from NHL patients, including those with HCV infection, remains to be elucidated. 
